These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 23091615)
1. Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction. Mapanga RF; Rajamani U; Dlamini N; Zungu-Edmondson M; Kelly-Laubscher R; Shafiullah M; Wahab A; Hasan MY; Fahim MA; Rondeau P; Bourdon E; Essop MF PLoS One; 2012; 7(10):e47322. PubMed ID: 23091615 [TBL] [Abstract][Full Text] [Related]
2. Glycation abolishes the cardioprotective effects of albumin during ex vivo ischemia-reperfusion. Mapanga RF; Joseph DE; Saieva M; Boyer F; Rondeau P; Bourdon E; Essop MF Physiol Rep; 2017 Jan; 5(2):. PubMed ID: 28126733 [TBL] [Abstract][Full Text] [Related]
3. Partial inhibition of the ubiquitin-proteasome system ameliorates cardiac dysfunction following ischemia-reperfusion in the presence of high glucose. Adams B; Mapanga RF; Essop MF Cardiovasc Diabetol; 2015 Jul; 14():94. PubMed ID: 26216448 [TBL] [Abstract][Full Text] [Related]
4. Detrimental effects of acute hyperglycaemia on the rat heart. Mapanga RF; Joseph D; Symington B; Garson KL; Kimar C; Kelly-Laubscher R; Essop MF Acta Physiol (Oxf); 2014 Mar; 210(3):546-64. PubMed ID: 24286628 [TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions. Wu Y; Xia ZY; Zhao B; Leng Y; Dou J; Meng QT; Lei SQ; Chen ZZ; Zhu J Int J Mol Med; 2017 Aug; 40(2):389-399. PubMed ID: 28714516 [TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid protects against myocardial ischemia-reperfusion injury by enhancing mitochondrial antioxidant mechanism mediated by glutathione and alpha-tocopherol in rats. Du Y; Ko KM Planta Med; 2006 Feb; 72(3):222-7. PubMed ID: 16534726 [TBL] [Abstract][Full Text] [Related]
7. Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia. Torregroza C; Yueksel B; Ruske R; Stroethoff M; Raupach A; Heinen A; Hollmann MW; Huhn R; Feige K Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926009 [TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. Rajamani U; Essop MF Am J Physiol Cell Physiol; 2010 Jul; 299(1):C139-47. PubMed ID: 20410435 [TBL] [Abstract][Full Text] [Related]
10. Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress. Tang WH; Cheng WT; Kravtsov GM; Tong XY; Hou XY; Chung SK; Chung SS Am J Physiol Cell Physiol; 2010 Sep; 299(3):C643-53. PubMed ID: 20573996 [TBL] [Abstract][Full Text] [Related]
11. Cardioprotective efficacy of a novel antioxidant mix VitaePro against ex vivo myocardial ischemia-reperfusion injury. Adluri RS; Thirunavukkarasu M; Zhan L; Maulik N; Svennevig K; Bagchi M; Maulik G Cell Biochem Biophys; 2013 Nov; 67(2):281-6. PubMed ID: 21960420 [TBL] [Abstract][Full Text] [Related]
12. The cardioprotective effects of diallyl trisulfide on diabetic rats with ex vivo induced ischemia/reperfusion injury. Jeremic JN; Jakovljevic VL; Zivkovic VI; Srejovic IM; Bradic JV; Bolevich S; Nikolic Turnic TR; Mitrovic SL; Jovicic NU; Tyagi SC; Jeremic NS Mol Cell Biochem; 2019 Oct; 460(1-2):151-164. PubMed ID: 31280436 [TBL] [Abstract][Full Text] [Related]
13. [The effects of alpha-linolenic acid on the functioning of the isolated heart during acute myocardial ischemia/reperfusion]. Kukoba TV; Shysh AM; Moĭbenko OO; Kotsiuruba AV; Kharchenko OV Fiziol Zh (1994); 2006; 52(5):12-20. PubMed ID: 17176834 [TBL] [Abstract][Full Text] [Related]
14. Hyperosmotic environment blunts effectivity of ischemic preconditioning against ischemia-reperfusion injury and improves ischemic tolerance in non-preconditioned isolated rat hearts. Zálešák M; BlaŽíček P; Pancza D; Gablovský I; Štrbák V; Ravingerová T Physiol Res; 2016 Dec; 65(6):1045-1051. PubMed ID: 27959577 [TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival. Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. Wright GL; Hanlon P; Amin K; Steenbergen C; Murphy E; Arcasoy MO FASEB J; 2004 Jun; 18(9):1031-3. PubMed ID: 15059965 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of T3 peptide, an active fragment of tumstatin, against ischemia/reperfusion injury in rat heart. Yasuda J; Okada M; Yamawaki H J Pharmacol Sci; 2019 Mar; 139(3):193-200. PubMed ID: 30827890 [TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress. Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951 [TBL] [Abstract][Full Text] [Related]
20. The blood contribution to early myocardial reperfusion injury is amplified in diabetes. McDonagh PF; Hokama JY; Copeland JG; Reynolds JM Diabetes; 1997 Nov; 46(11):1859-67. PubMed ID: 9356037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]